Q32 Bio (QTTB) Income towards Parent Company (2017 - 2026)

Q32 Bio has reported Income towards Parent Company for 10 years, with the latest figure at -$7.7 million in Q1 2026.

• For the quarter ending Q1 2026, Income towards Parent Company rose 30.0% year-over-year to -$7.7 million; the trailing twelve-month figure through Mar 2026 stood at $33.1 million (up 156.78% YoY), and the FY2025 full-year result was $29.8 million, up 164.68% from the prior year.
• Income towards Parent Company for Q1 2026 stood at -$7.7 million, down from $57.7 million in the prior quarter.
• The five-year high for Income towards Parent Company was $92.7 million in Q1 2022, with the low at -$34.6 million in Q4 2022.
• Average Income towards Parent Company over 5 years is -$4.7 million, with a median of -$11.0 million recorded in 2025.
• Year-over-year, Income towards Parent Company jumped 8735.88% in 2022 and tumbled 1015.44% in 2025.
• Tracing QTTB's Income towards Parent Company over 5 years: stood at -$34.6 million in 2022, then rose by 21.52% to -$27.1 million in 2023, then jumped by 47.7% to -$14.2 million in 2024, then jumped by 506.86% to $57.7 million in 2025, then plunged by 113.38% to -$7.7 million in 2026.
• The last three Income towards Parent Company figures came in at -$7.7 million (Q1 2026), $57.7 million (Q4 2025), and -$7.4 million (Q3 2025), per Business Quant data.

Peer Comparison